Lilly makes medicines that help people live longer, healthier, and more active lives. We at Lilly promise to operate our business with absolute integrity, to earn the trust of all, to set the highest standards for our performance and for the performance of our products, and to demonstrate caring and respect for all those who share in our mission and are touched by our work.
The company conducts business in a highly regulated environment and is committed to market its products responsibly and in a manner that safeguards patients and promotes science & knowledge. The company has global policies, re-affirming its commitment to, and expectations of its employees to, ethical interactions. This includes company expectations regarding the promotion of company medicines and devices.
All employees must act ethically, and comply with all applicable laws, regulations, and industry codes of practice that govern company interactions with external parties, including healthcare providers, government and public officials, and private individuals. Employees must act ethically in both the public and private sector. In fact, Lilly has a long-standing set of internal guidelines (The Red Book) that provides the basis for all employees' making of ethical decisions across the spectrum of groups, individuals, and scenarios.
To help assure stakeholders that Lilly's business transactions are with integrity and beyond reproach, Lilly implemented an enhanced anti-corruption and transparency program called Integrity in Business. The program helps to document all business transactions with third parties, partners, and healthcare providers are appropriate, transparent, and legitimate. The overall objective is to be above board on all our business practices.